Survodutide
A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity
Boehringer Ingelheim · Phase 1 · Active, not recruiting · Enrollment 44
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| BI 456906 formulation A (Reference) then BI 456906 formulation B2 (Test) | n/r | n/r | n/r | n/r |
| BI 456906 formulation B2 (Test) then BI 456906 formulation A (Reference) | n/r | n/r | n/r | n/r |
Not shown
- BI 456906 formulation A (Reference) then BI 456906 formulation B2 (Test): endpoint not reported
- BI 456906 formulation B2 (Test) then BI 456906 formulation A (Reference): endpoint not reported